Correction to: How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural Enhancement.

Severin, Thomas; Corriol-Rohou, Solange; Bucci-Rechtweg, Christina; An Haack, Kristina; Fuerst-Recktenwald, Sabine; Lepola, Pirkko; Norjavaara, Ensio; Dehlinger-Kremer, Martine; Haertter, Sebastian; Cheung, S Y Amy

Severin, Thomas; Corriol-Rohou, Solange; Bucci-Rechtweg, Christina; An Haack, Kristina; Fuerst-Recktenwald, Sabine; Lepola, Pirkko; Norjavaara, Ensio; Dehlinger-Kremer, Martine; Haertter, Sebastian; Cheung, S Y Amy.

Afiliação

Severin T; Global Drug Development, Novartis Pharma AG, Novartis Campus, 4002, Basel, Switzerland. thomas.severin@novartis.com.
Corriol-Rohou S; Global Regulatory Excellence, AstraZeneca, Paris, France.
Bucci-Rechtweg C; Global Health Policy, Regulatory Affairs, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
An Haack K; R&D/Clinical Development Rare Diseases, Sanofi/Genzyme, Chilly-Mazarin, France.
Fuerst-Recktenwald S; Product Development Neurology, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Lepola P; Department of Children and Adolescents, Helsinki University Hospital, Helsinki, Finland.
Norjavaara E; Global Medicines Development, AstraZeneca, Mölndal, Sweden.
Dehlinger-Kremer M; Pediatric Development, Synteract, & EUCROF, Munich, Germany.
Haertter S; Translational Medicine & Clinical Pharmacology, Boehringer-Ingelheim, Ingelheim, Germany.
Cheung SYA; Certara, Princeton, NJ, USA.

Ther Innov Regul Sci ; 54(5): 1085, 2020 Sep.

Article em En | MEDLINE | ID: mdl-32865808

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article